Efficacy and Safety of Intra-gastric Balloon Placement in Dialyzed Patients Awaiting Kidney Transplantation

Overview

Journal Obes Surg

Date 2018 Nov 27

PMID 30474792

Citations 3

Authors

Severine Beaudreuil

Franck Iglicki

Severine Ledoux

Michelle Elias

Erika NNang Obada

Hadia Hebibi

Emmanuel Durand

Bernard Charpentier

Benoit Coffin

Antoine Durrbach

Affiliations

Soon will be listed here.

Abstract

Background: The number of obese patients who are candidates for renal transplantation has considerably increased, but obesity can be a barrier to kidney transplantation. Weight loss is often difficult through diet alone. We studied the efficacy and tolerance of the intra-gastric balloon (IGB) procedure in obese patients who were undergoing dialysis and were candidates for a renal transplantation.

Patients And Methods: Obese patients (BMI > 30 kg/m) who were candidates for renal transplantation were prospectively included in the study between 2010 and 2012. The balloon was inserted and removed during a gastric endoscopy under general anesthesia. The treatment lasted 6 months. The end point was a decrease in BMI after 6 months. Body impedance spectrometry (BIS) and nutritional statute were evaluated initially and then after IGB removal.

Results: Seventeen patients (nine females and eight males) with a mean age of 53.4 years [19.4-69.4] were included. The decrease in body mass index (BMI) during the 6-month placement was 3 kg/m (from 37.7 to 34.4 kg/m). The mean weight loss was 7 kg. The mean percentage of excess weight loss after 6 months was 20.2 (± 11.4). The tolerance was good without any complications. Eleven patients underwent kidney transplantation.

Conclusion: IGB in obese dialyzed patients who are candidates for renal transplantation is safe and effective. However, the amount of weight loss can vary.

Citing Articles

Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations.

Ozbek L, Abdel-Rahman S, Unlu S, Guldan M, Copur S, Burlacu A Medicina (Kaunas). 2024; 60(10).

PMID: 39459455 PMC: 11509396. DOI: 10.3390/medicina60101668.

[Intragastric balloon for weight reduction: rationale, benefits, risks and indications].

Wu L, Dai X, Zhao W, Huang H, Mo L, Wu X Nan Fang Yi Ke Da Xue Xue Bao. 2020; 40(10):1525-1529.

PMID: 33118505 PMC: 7606238. DOI: 10.12122/j.issn.1673-4254.2020.10.21.

Endoscopic intragastric balloon: a gimmick or a viable option for obesity?.

Gollisch K, Raddatz D Ann Transl Med. 2020; 8(Suppl 1):S8.

PMID: 32309412 PMC: 7154325. DOI: 10.21037/atm.2019.09.67.

References

Bardonnaud N, Pillot P, Lillaz J, Delorme G, Chabannes E, Bernardini S . Outcomes of renal transplantation in obese recipients. Transplant Proc. 2012; 44(9):2787-91. DOI: 10.1016/j.transproceed.2012.09.031. View

Scandling J . Kidney transplant candidate evaluation. Semin Dial. 2006; 18(6):487-94. DOI: 10.1111/j.1525-139X.2005.00094.x. View

Johnson D, Isbel N, Brown A, Kay T, Franzen K, Hawley C . The effect of obesity on renal transplant outcomes. Transplantation. 2002; 74(5):675-81. DOI: 10.1097/00007890-200209150-00015. View

Gill J, Rose C, Pereira B, Tonelli M . The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int. 2007; 71(5):442-7. DOI: 10.1038/sj.ki.5002072. View

Wolfe R, Ashby V, Milford E, Ojo A, Ettenger R, Agodoa L . Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341(23):1725-30. DOI: 10.1056/NEJM199912023412303. View

Lin M, Tavakol M, Sarin A, Amirkiai S, Rogers S, Carter J . Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013; 9(5):653-8. DOI: 10.1016/j.soard.2013.02.013. View

Turgeon N, Perez S, Mondestin M, Davis S, Lin E, Tata S . The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol. 2012; 23(5):885-94. DOI: 10.1681/ASN.2011050476. View

Genco A, Maselli R, Frangella F, Cipriano M, Forestieri P, Delle Piane D . Intragastric balloon for obesity treatment: results of a multicentric evaluation for balloons left in place for more than 6 months. Surg Endosc. 2014; 29(8):2339-43. DOI: 10.1007/s00464-014-3957-0. View

Al-Momen A, El-Mogy I . Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005; 15(1):101-5. DOI: 10.1381/0960892052993558. View

10.

Holley J, Monaghan J, Byer B, Bronsther O . An examination of the renal transplant evaluation process focusing on cost and the reasons for patient exclusion. Am J Kidney Dis. 1998; 32(4):567-74. DOI: 10.1016/s0272-6386(98)70018-6. View

11.

Schwarznau A, Matevossian E, Novotny A, Stangl M . Outcome of living donor renal transplantation in obese recipients. Transplant Proc. 2008; 40(4):921-2. DOI: 10.1016/j.transproceed.2008.03.047. View

12.

Leavey S, McCullough K, Hecking E, Goodkin D, Port F, Young E . Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001; 16(12):2386-94. DOI: 10.1093/ndt/16.12.2386. View

13.

Postorino M, Marino C, Tripepi G, Zoccali C . Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol. 2009; 53(15):1265-72. DOI: 10.1016/j.jacc.2008.12.040. View

14.

Molnar M, Kovesdy C, Mucsi I, Bunnapradist S, Streja E, Krishnan M . Higher recipient body mass index is associated with post-transplant delayed kidney graft function. Kidney Int. 2011; 80(2):218-24. PMC: 5489124. DOI: 10.1038/ki.2011.114. View

15.

Furriel F, Parada B, Campos L, Moreira P, Castelo D, Dias V . Pretransplantation overweight and obesity: does it really affect kidney transplantation outcomes?. Transplant Proc. 2011; 43(1):95-9. DOI: 10.1016/j.transproceed.2010.12.027. View

16.

Imaz I, Martinez-Cervell C, Garcia-Alvarez E, Sendra-Gutierrez J, Gonzalez-Enriquez J . Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008; 18(7):841-6. DOI: 10.1007/s11695-007-9331-8. View

17.

Singh D, Lawen J, Alkhudair W . Does pretransplant obesity affect the outcome in kidney transplant recipients?. Transplant Proc. 2005; 37(2):717-20. DOI: 10.1016/j.transproceed.2004.12.033. View

18.

Grosso G, Corona D, Mistretta A, Zerbo D, Sinagra N, Giaquinta A . The role of obesity in kidney transplantation outcome. Transplant Proc. 2012; 44(7):1864-8. DOI: 10.1016/j.transproceed.2012.06.043. View

19.

Stevens J, Cai J, Pamuk E, Williamson D, Thun M, Wood J . The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998; 338(1):1-7. DOI: 10.1056/NEJM199801013380101. View

20.

Cook S, MacLaughlin H, Macdougall I . A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease. Nephrol Dial Transplant. 2007; 23(1):263-8. DOI: 10.1093/ndt/gfm511. View